Anti-fibrillarin antibody in African American patients with systemic sclerosis: Immunogenetics, clinical features, and survival analysis

Journal of Rheumatology

Volumn 38, Issue 8, 2011, Pages 1622-1630

  Sharif, Roozbeh ^a   Fritzler, Marvin J ^b   Mayes, Maureen D ^a   Gonzalez, Emilio B ^c   McNearney, Terry A ^c,k   Draeger, Hilda ^d   Baron, Murray ^e,l   Furst, Daniel E ^f   Khanna, Dinesh K ^f   Del Junco, Deborah J ^a   Molitor, Jerry A ^g   Schiopu, Elena ^h   Phillips, Kristine ^h   Seibold, James R ^h,m   Silver, Richard M ⁱ   Simms, Robert W ^j   Perry, Marilyn ^a   Rojo, Carlos ^a   Charles, Julio ^a   Zhou, Xiaodong ^a   Agarwal, Sandeep K ^a   Reveille, John D ^a   Assassi, Shervin ^a   Arnett, Frank C ^a   Pope, Janet E ⁿ   Markland, Janet ⁿ   Robinson, David ⁿ   Jones, Niall ⁿ   Khalidi, Nader ⁿ   Docherty, Peter ⁿ   Abu Hakima, Maysan ⁿ   LeClercq, Sharon ⁿ   Sutton, Evelyn ⁿ   Smith, Douglas ⁿ   Mathieu, Jean Pierre ⁿ   Masetto, Alejandra ⁿ   Kaminska, Elzbieta ⁿ   Ligier, Sophie ⁿ   more..

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k ELI LILLY AND COMPANY   (United States)

^l Canadian Scleroderma Research Group   (Canada)

^m Scleroderma Research Consultants   (United States)

ⁿ NONE

more..

Author keywords

Anti U3 RNP; Digital ulcer; Genisos; HLA DRB1; Scleroderma; Scleroderma family registry

Indexed keywords

FIBRILLARIN ANTIBODY; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; RIBONUCLEOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOOT ULCER; HLA TYPING; HUMAN; IMMUNOGENETICS; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PERICARDITIS; PRIORITY JOURNAL; SURVIVAL; SYSTEMIC SCLEROSIS;

ADULT; AFRICAN AMERICANS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CHROMOSOMAL PROTEINS, NON-HISTONE; FEMALE; GENE FREQUENCY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DRB1 CHAINS; HUMANS; IMMUNOGENETICS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SURVIVAL ANALYSIS;

EID: 79961109536     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110071     Document Type: Article

References (40)

1. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55. (Pubitemid 36959206)
2. Nietert PJ, Mitchell HC, Bolster MB, Shaftman SR, Tilley BC, Silver RM. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol 2006;33:263-8. (Pubitemid 43209301)
3. Assassi S, Del Junco D, Sutter K, McNearney TA, Reveille JD, Karnavas A, et al. Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 2009;61:1403-11.
4. Beall AD, Nietert PJ, Taylor MH, Mitchell HC, Shaftman SR, Silver RM, et al. Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis. J Rheumatol 2007;34:1277-82. (Pubitemid 46898109)
5. Reveille JD, Fischbach M, McNearney T, Friedman AW, Aguilar MB, Lisse J, et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 2001;30:332-46. (Pubitemid 32298859)
6. Ochs RL, Lischwe MA, Spohn WH, Busch H. Fibrillarin: a new protein of the nucleolus identified by autoimmune sera. Biol Cell 1985;54:123-33. (Pubitemid 16250128)
7. Ceribelli A, Cavazzana I, Franceschini F, Airo P, Tincani A, Cattaneo R, et al. Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. J Rheumatol 2010;37:2071-5.
8. Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994;37:902-6. (Pubitemid 24184543)
9. Okano Y, Steen VD, Medsger TA Jr. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992;35:95-100.
10. Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, et al. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum 1996;39:1151-60. (Pubitemid 26240228)
11. Tormey VJ, Bunn CC, Denton CP, Black CM. Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology 2001;40:1157-62.
12. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35:35-42. (Pubitemid 41111469)
13. Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA Jr. Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum 2009;60:1112-8.
14. Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2010;69:822-7.
15. Satoh M, Akizuki M, Kuwana M, Mimori T, Yamagata H, Yoshida S, et al. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma. J Rheumatol 1994;21:111-4. (Pubitemid 24044929)
16. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988;31:525-32.
17. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994;37:75-83. (Pubitemid 24027696)
18. Assassi S, Sharif R, Lasky RE, McNearney TA, Estrada YMR, Draeger H, et al. Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. Arthritis Res Ther 2010;12:R166.
19. Mayes MD. The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosis. Curr Rheumatol Rep 2000;2:512-6.
20. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
21. Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
22. Olsen ML, Arnett FC, Reveille JD. Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus. Arthritis Rheum 1993;36:94-104. (Pubitemid 23048685)
23. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001;17:1236-7. (Pubitemid 33735355)
24. Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, Sahin U, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999;17:555-61. (Pubitemid 29262918)
25. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6. (Pubitemid 24031593)
26. Steen VD, Medsger TA Jr, Rodnan GP. D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med 1982;97:652-9. (Pubitemid 13251633)
27. Reveille JD, Durban E, Goldstein R, Moreda R, Arnett FC. Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum 1992;35:216-8.
28. Reveille JD. Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep 2003;5:160-7.
29. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture. Arthritis Rheum 1998;41:1161-72. (Pubitemid 28313416)
30. Hughes LB, Morrison D, Kelley JM, Padilla MA, Vaughan LK, Westfall AO, et al. The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum 2008;58:349-58. (Pubitemid 351294869)
31. Hultman P, Enestrom S, Pollard KM, Tan EM. Anti-fibrillarin autoantibodies in mercury-treated mice. Clin Exp Immunol 1989;78:470-7.
32. Chen M, Rockel T, Steinweger G, Hemmerich P, Risch J, von Mikecz A. Subcellular recruitment of fibrillarin to nucleoplasmic proteasomes: implications for processing of a nucleolar autoantigen. Mol Biol Cell 2002;13:3576-87. (Pubitemid 35191376)
33. Havarinasab S, Pollard KM, Hultman P. Gold- and silver-induced murine autoimmunity - requirement for cytokines and CD28 in murine heavy metal-induced autoimmunity. Clin Exp Immunol 2009;155:567-76.
34. Pollard KM, Hultman P, Kono DH. Toxicology of autoimmune diseases. Chem Res Toxicol 2010;23:455-66.
35. Arnett FC, Fritzler MJ, Ahn C, Holian A. Urinary mercury levels in patients with autoantibodies to U3-RNP (fibrillarin). J Rheumatol 2000;27:405-10. (Pubitemid 30095473)
36. Rosen A, Casciola-Rosen L, Wigley F. Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma. Curr Opin Rheumatol 1997;9:538-43. (Pubitemid 27504211)
37. Pollard KM, Reimer G, Tan EM. Autoantibodies in scleroderma. Clin Exp Rheumatol 1989;7 Suppl 3:S57-S62. (Pubitemid 20058418)
38. Sacks DG, Okano Y, Steen VD, Curtiss E, Shapiro LS, Medsger TA Jr. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. J Rheumatol 1996;23:639-42. (Pubitemid 26139635)
39. Laing TJ, Gillespie BW, Toth MB, Mayes MD, Gallavan RH Jr, Burns CJ, et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997;40:734-42. (Pubitemid 27157581)
40. McNearney TA, Reveille JD, Fischbach M, Friedman AW, Lisse JR, Goel N, et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 2007;57:318-26. (Pubitemid 47164096)